Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Clinofibrate (Lipoclin)(IC50 of 0.47 mM), a lipid-lowering agent, inhibits hydroxymethylglutaryl coenzyme A reductase (HMGCR). It is utilized to control high cholesterol and triacylglyceride levels in the blood.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 39.00 | |
10 mg | In stock | $ 55.00 | |
25 mg | In stock | $ 113.00 | |
50 mg | In stock | $ 183.00 | |
100 mg | In stock | $ 289.00 | |
200 mg | In stock | $ 428.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 40.00 |
Description | Clinofibrate (Lipoclin)(IC50 of 0.47 mM), a lipid-lowering agent, inhibits hydroxymethylglutaryl coenzyme A reductase (HMGCR). It is utilized to control high cholesterol and triacylglyceride levels in the blood. |
Targets&IC50 | HMG-CoA reductase:0.47 mM |
In vitro | In the treatment of arteriosclerosis in rats, Clinofibrate significantly reduces high plasma cholesterol levels. When used in CAPD patients, it effectively decreases very low-density lipoprotein levels. Typically, Clinofibrate (600 mg/daily) reduces serum triglycerides by 36% and very low-density lipoprotein triglycerides by 48%. Additionally, it ameliorates abnormalities in low-density and high-density lipoprotein compositions, markedly increasing the content of high-density lipoprotein cholesterol. |
In vivo | Clinofibrate, with an IC50 of 40 μM, acts on the activity of human liver 3α-hydroxysteroid dehydrogenase. |
Synonyms | S-8527, Lipoclin |
Molecular Weight | 468.58 |
Formula | C28H36O6 |
CAS No. | 30299-08-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 87 mg/mL (185.7 mM)
Ethanol: 87 mg/mL (185.7 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Clinofibrate 30299-08-2 Autophagy Metabolism HMG-CoA Reductase S 8527 S-8527 HMG-CoA Reductase (HMGCR) inhibit Inhibitor S8527 Lipoclin inhibitor